PTC Therapeutics Inc. buy Morgan Stanley
Start price
08.01.26
/
50%
€66.50
Target price
08.01.27
-
Performance (%)
-5.17%
Price
19.08.26
€61.82
Summary
This prediction is currently active. With a performance of -5.17%, the BUY prediction for PTC Therapeutics Inc. by Morgan_Stanley is down slightly. This prediction currently runs until 08.01.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -1.404% | -1.404% |
| iShares Core DAX® | -1,06 % | 5,01 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % |
| iShares S&P 500 | -1,78 % | 1,39 % |
Comments by Morgan_Stanley for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Morgan_Stanley for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.60
20.08.25
20.08.25
€61.05
20.08.26
20.08.26
51.59%
19.08.26
19.08.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.60
07.03.25
07.03.25
€64.54
07.03.26
07.03.26
9.05%
08.03.26
08.03.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.80
13.12.24
13.12.24
€63.72
13.12.25
13.12.25
43.84%
14.12.25
14.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.80
19.12.23
19.12.23
€25.54
19.12.24
19.12.24
73.39%
20.12.24
20.12.24